- Home
- TNXP vs BANL Comparison
TNXP vs BANL Comparison
Compare TNXP & BANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- BANL
- Stock Information
- Founded
- TNXP 2007
- BANL 2015
- Country
- TNXP United States
- BANL Malaysia
- Employees
- TNXP N/A
- BANL N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- BANL Oil Refining/Marketing
- Sector
- TNXP Health Care
- BANL Energy
- Exchange
- TNXP Nasdaq
- BANL Nasdaq
- Market Cap
- TNXP 19.5M
- BANL 22.8M
- IPO Year
- TNXP N/A
- BANL 2023
- Fundamental
- Price
- TNXP $0.61
- BANL $0.89
- Analyst Decision
- TNXP Strong Buy
- BANL
- Analyst Count
- TNXP 2
- BANL 0
- Target Price
- TNXP $53.50
- BANL N/A
- AVG Volume (30 Days)
- TNXP 202.6M
- BANL 8.9K
- Earning Date
- TNXP 11-12-2024
- BANL 09-12-2024
- Dividend Yield
- TNXP N/A
- BANL N/A
- EPS Growth
- TNXP N/A
- BANL N/A
- EPS
- TNXP N/A
- BANL N/A
- Revenue
- TNXP $11,291,000.00
- BANL $521,173,543.00
- Revenue This Year
- TNXP $64.71
- BANL N/A
- Revenue Next Year
- TNXP $24.49
- BANL N/A
- P/E Ratio
- TNXP N/A
- BANL N/A
- Revenue Growth
- TNXP 183.05
- BANL 24.34
- 52 Week Low
- TNXP $0.12
- BANL $0.55
- 52 Week High
- TNXP $14.08
- BANL $1.79
- Technical
- Relative Strength Index (RSI)
- TNXP 75.02
- BANL 44.04
- Support Level
- TNXP $0.32
- BANL $0.77
- Resistance Level
- TNXP $0.72
- BANL $0.91
- Average True Range (ATR)
- TNXP 0.15
- BANL 0.05
- MACD
- TNXP 0.04
- BANL -0.00
- Stochastic Oscillator
- TNXP 39.61
- BANL 54.55
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About BANL CBL International Limited
CBL International Ltd is a company that provides a complete range of marine fuel logistics services. It sources the highest quality marine fuel from its trusted suppliers and ensures timely delivery to its customers. The company's expertise lies in providing a seamless and efficient one-stop solution for vessel refueling needs, making it a reliable partner for shipping companies. CBL International Ltd has a strong presence in China, Hong Kong, and Malaysia.